-
EP2210597
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2210597
| EP2210597 - Bacterial virulence modifying agents [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 02.12.2011 Database last updated on 13.11.2024 | Most recent event Tooltip | 02.12.2011 | Application deemed to be withdrawn | published on 04.01.2012 [2012/01] | Applicant(s) | For all designated states Creative Antibiotics Sweden AB Box 7953 907 19 Umeå / SE | [2010/30] | Inventor(s) | 01 /
Kauppi, Anna, Maria Morkullevägen 18M 906 51 Umeå / SE | 02 /
Nordfelth, Olov, Roland Bofinsvägen 4B 906 51 Umeå / SE | 03 /
Wolf-Watz, Hans, Olof Djäkneböle 725 905 87 Umeå / SE | 04 /
Elofsson, Jan, Mikael, Christian Sjöfruvägen 13 907 51 Umeå / SE | [2010/30] | Representative(s) | Mattsson, Niklas Awapatent AB Drottninggatan 97 P.O. Box 45 086 104 30 Stockholm / SE | [N/P] |
| Former [2010/30] | Mattsson, Niklas Awapatent AB P.O. Box 45086 104 30 Stockholm / SE | Application number, filing date | 10161123.4 | 04.09.2003 | [2010/30] | Priority number, date | SE20020002613 | 04.09.2002 Original published format: SE 0202613 | [2010/30] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2210597 | Date: | 28.07.2010 | Language: | EN | [2010/30] | Type: | A3 Search report | No.: | EP2210597 | Date: | 12.01.2011 | [2011/02] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 10.12.2010 | Classification | IPC: | A61K31/15 | [2010/30] | CPC: |
C07D285/14 (EP,US);
A61K31/15 (EP,US);
A61K31/167 (EP,US);
C07C235/64 (EP,US);
C07C251/86 (EP,US);
C07C323/42 (EP,US);
C07D213/88 (EP,US);
C07D307/68 (EP,US);
C12Q1/18 (EP,US);
G01N2333/24 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2010/30] | Title | German: | Mittel zur Modifikation der Bakterienvirulenz | [2010/30] | English: | Bacterial virulence modifying agents | [2010/30] | French: | Agents de modification de virulence bactérienne | [2010/30] | Examination procedure | 13.07.2011 | Application deemed to be withdrawn, date of legal effect [2012/01] | 19.08.2011 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2012/01] | Parent application(s) Tooltip | EP03794402.2 / EP1543148 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20030794402) is 10.01.2006 | Fees paid | Renewal fee | 27.04.2010 | Renewal fee patent year 03 | 27.04.2010 | Renewal fee patent year 04 | 27.04.2010 | Renewal fee patent year 05 | 27.04.2010 | Renewal fee patent year 06 | 27.04.2010 | Renewal fee patent year 07 | 06.09.2010 | Renewal fee patent year 08 | Penalty fee | Additional fee for renewal fee | 30.09.2011 | 09 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [XPI]WO02070464 (ARPIDA AG [CH], et al) [XP] 1-3,6 * page 1, lines 21-25; claim 7 * [I] 4; | [A]WO9958714 (PASTEUR INSTITUT [FR], et al) [A] 1-6 * the whole document *; | [L]WO2004022775 (INNATE PHARMACEUTICALS AB [SE], et al) | [A] - MRUTHYUNJAYASWAMY B H M ET AL, "Synthesis and pharmacological activity of 2H-3-(various substituted indole-2'-carboxamidyl)-3,4-dihydro-1,3-benzoxazines and 2H-3-(2',5'-disubstituted indol-3'-yl)methyl-1,3-benzoxazoles", INDIAN JOURNAL OF CHEMISTRY. SECTION B: ORGANIC AND MEDICINAL CHEMISTRY, COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (C S I R), IN, (19980101), vol. 37, no. 5, ISSN 0376-4699, pages 453 - 460, XP009117081 [A] 1-6 * Scheme I, compounds 3 a-m; Page 458, section "Antibacterial and antifungal activity" * | by applicant | US6136542 | SU1685935 | SU1226807 | - MIKHAILITSYN F.S.; LEBEDEVA M.N.; KOZYREVA N,P.; LYCHKO N.D.; DRUSVYATSKAYA S.K.; UVAROVA, MED. PARAZITOL. PARAZIT. BOLEZNI., (1991), pages 36 - 38 | - AINSCOUGH E.W; BRODIE A.M.; DENNY W.A.; FINLAY G.J.; GOTHE S.A.; RANFORD J.D., J. INORG. BIOCHEM., (1999), pages 125 - 133 | - FINCH, RG, "Antibiotic resistance", J. ANTIMIROBIAL CHEMOTHER., (1998), vol. 42, pages 125 - 128 | - COHEN, M.L., "Changing patterns of infectious disease", NATURE, (2000), vol. 406, pages 762 - 767 | - AN, H.; COOK, PD, "Methodologies for generating solution-phase combinatorial libraries", CHEM. REV., (2000), vol. 100, pages 3311 - 3340 | - CORK, D.; HIRD, N., "Work-up strategies far high-throughput solution synthesis", DRUG DISCOVERY TODAY, (2002), vol. 7, pages 56 - 63 | - LOU, B., "Navel strategies far solid-phase construction of small-molecule combinatorial libraries", DRUG DISCOVERY TODAY, (2001), vol. 6, pages 1288 - 1294 | - BUYSSE, J .M., "The role of genomics in antibacterial target discovery", CURR, MED CHEM., (2001), vol. 8, pages 1713 - 1726, XP002980236 | - MCDEVITT, D.; ROSENBERG, M, "Exploiting genomics to discover new antibiotics", TRENDS MICROBIOL., (2001), vol. 9, pages 611 - 617 | - SUNDBERG, S.A, "High-throughput and ultra-high throughput screening: solution- and cell- based approaches", CURR. OPIN. BIOTECHNOL., (2000), vol. 11, doi:doi:10.1016/S0958-1669(99)00051-8, pages 47 - 53, XP002196557 DOI: http://dx.doi.org/10.1016/S0958-1669(99)00051-8 | - HERTZBERG, R.P.; POPE, A.J., "High-throughput screening: new technology for the 21st century", CURR. OPIN. CHEM. BIOL., (2000), vol. 4, doi:doi:10.1016/S1367-5931(00)00110-1, pages 445 - 451, XP002256444 DOI: http://dx.doi.org/10.1016/S1367-5931(00)00110-1 | - TRIAS, J, "The role of combichem in antibiotic discovery", CURR. OPIN MICROBIOL., (2001), vol. 4, pages 520 - 525 | - GOLDSCHMIDT, R.M.; MACIELAG, M.; HLASTA, D.J.; BARRETT, J.F., "Inhibition of virulence factors in bacteria", CURR. PHARM. DESIGN, (1997), vol. 3, pages 125 - 142 | - ALKSNE, L.E; PROJAN, S.J, "Bacterial virulence as target for antimicrobial chemotherapy", CURR. OPIN. BIOTECHNOL., (2000), vol. 11, doi:doi:10.1016/S0958-1669(00)00155-5, pages 625 - 636, XP002980243 DOI: http://dx.doi.org/10.1016/S0958-1669(00)00155-5 | - STOCKWELL, B.R., "Frontiers in chemical genetics", TRENDS BIOTECHNOL., (2000), vol. 18, doi:doi:10.1016/S0167-7799(00)01499-2, pages 449 - 455, XP004237207 DOI: http://dx.doi.org/10.1016/S0167-7799(00)01499-2 | - SHOGREN-KNAAK, M.A.; ALAIMO, P.J.; SHOKAT, K.M., "Recent advances in chemical approaches to the study of biological systems", ANML REV. CELL DEV. BIOL., (2001), vol. 17, pages 405 - 433 | - CORNELIS, G.R.; WOLF-WATZ, H, "The Yersinia Yop virulon: A bacterial system for subverting eukaryotic cells", MOL. MICROBIOL., (1997), vol. 23, pages 861 - 867 | - CORNELIS, G.R., "Molecular and cell biology aspects of plague", PROC. NAT ACAD SCI. USA, (2000), vol. 97, doi:doi:10.1073/pnas.97.16.8778, pages 8778 - 8783, XP002399287 DOI: http://dx.doi.org/10.1073/pnas.97.16.8778 | - HUECK, CJ, "Type III protein secretion systems in bacterial pathogens of animals and plants", MICROBIOL. MOL. BIOL. REV., (1998), vol. 62, pages 379 - 433, XP000915080 | - CORNELIS, G.R; GIJSEGEM, F.V., "Assembly and function of type III secretory systems", ANNU. REV. MICROBIOL., (2000), vol. 54, doi:doi:10.1146/annurev.micro.54.1.735, pages 735 - 774, XP002968578 DOI: http://dx.doi.org/10.1146/annurev.micro.54.1.735 | - GALIMAND, M. ET AL., "Multidrug resistance in Yersinia pestis mediated by a transferable plasmid", NEW ENGLAND J. MED, (1997), vol. 337, pages 677 - 680 | - GUIYOULE, A ET AL., "Transferable plasmid-mediated resistance to streptomycin in a clinical isolate ofyersinia pestis", EMERGING LNF. DISEASE, (2001), vol. 7, pages 43 - 48 | - HAWLEY, R.J.; EITZEN JR., E.M., "Biological weapons - a primer for microbiologists", ANNU. REV. MICROBIOL, (2001), vol. 55, pages 235 - 253 | - INGLESBY, T.V. ET AL., "Plague as a biological weapon", JAMA, (2000), vol. 283, pages 2281 - 2290 | - ACHTMAN, M ET AL., "Yersinia pestis, the causative agent of plague, is a recently emerged clone of yersimia pseudotuberculosis", PROC. NAT. ACAD. SCI. USA, (1999), vol. 96, pages 14043 - 14048 | - OLSSON, O.; KONCZ, C.; SZALAY, A, "A The use of the luxA gene of the bacterial luciferase operon as a reporter gene", MOL. GEN. GENET., (1988), vol. 215, doi:doi:10.1007/BF00331295, pages 1 - 9, XP000027951 DOI: http://dx.doi.org/10.1007/BF00331295 | - FORSBERG, A; ROSQVIST, R, "In vivo expression of virulence genes ofyersinia pseudotuberculosis", INF. AGENTS DISEASE, (1994), vol. 2, pages 275 - 278, XP002974332 | - BöLIN, I.; WOLF- WATZ, H, "Molecular cloning of the temperature-inducible outer membrane protein 1 ofY. pseudotuberculosis", INFECT. IMMUN., (1984), vol. 43, pages 72 - 78, XP002974333 | - BöLIN, I.; WOLF-WATZ, H, "The plasmid-encoded Yop2b protein of Yersinia pseudotuberculosis is a virulence determinant regulated by calcium and temperature at the level of transcription", MOL. MCROBIOL., (1988), vol. 2, doi:doi:10.1111/j.1365-2958.1988.tb00025.x, pages 237 - 245, XP002974334 DOI: http://dx.doi.org/10.1111/j.1365-2958.1988.tb00025.x | - MACIELAG, M.J. ET AL., "Substituted salicylanilides as inhibitors of two-component regulatory systems in bacteria", J. MED. CHEM, (1998), vol. 41, doi:doi:10.1021/jm9803572, pages 2939 - 2945, XP002496564 DOI: http://dx.doi.org/10.1021/jm9803572 |